| |
Techtran launched its operations at Leeds University in April 2003. Since that time, it has been working in partnership with academic entrepreneurs to develop opportunities. Techtran has established several spin out companies which are now part of IP Group PLC's broader portfolio. Further details of the Leeds spin outs and other portfolio companies can be found at www.ip2ipo.com/ipo/portfolio.
Incubation level
 |
|
Aptuscan Ltd
Description: Aptuscan is driving the development of next generation bio-molecular detection applicable to the healthcare market. The company is using novel peptide aptamer technology based on the work of Dr Paul Ko Ferrigno. Peptide aptamers possess the binding characteristics of antibodies, but in contrast can detect conformational changes, and remain fully functional and stable when bound to inorganic surfaces. Contact: Cassie O’Grady
|
 |
|
Athena3D Ltd
Description: Athena3D Ltd is developing techniques for the creation of photo-realistic, three-dimensional digital images of objects using a patented optical scanning technology. The technology is capable of rapidly producing high resolution 3D representations of objects with a co-registered colour image. The company is currently focused on radically improving the quality of metrology of moulded components. Contact: Charles Tavner
|
 |
|
DyeCat Ltd
Description: Dyecat is developing new catalyst systems for polymers with the aim of improving the sustainability of polymer colouration and fibre. Website: www.dyecat.com Contact: Rob Rule
|
 |
|
Encos Ltd
Description: Encos ultimately aims to replace concrete as a structural material in all applications with a fully sustainable product made from 100% recycled and waste materials. Contact: Simon Graindorge
|
 |
|
Escubed Ltd
Description: Escubed has been established to provide particle characterisation services to the pharmaceutical food, personal care and other industries. Contact: Simon Lawson
|
 |
|
Metabio Ltd
Description: Metabio Ltd is developing diagnostics for a range of reproductive diseases and disorders, with preeclampsia being the initial focus. Metabio has a range of proprietary bio-markers it is continuing to validate while discovering new markers of great significance. Metabio intends to commercialize this range of markers onto a range of diagnostics kits and analytical platforms as well as point of care and bed-side tests. Contact: Andy Round
|
 |
|
Organisense Ltd
Description: Organisense Ltd is developing online sensors for applications in a number of industries. The technology is based on sensing membrane organisation and fluidity and has significant advantages in low cost, small size, speed, robustness, relevance and automation (online functionality). Organisense is currently developing sensors for the water treatment, pharmaceutical, consumer goods and biodefence industries. Contact: Simon Graindorge
|
 |
|
Ovatus Ltd
Description: Ovatus is developing a novel delivery based on gut bacteria for the treatment of a wide variety of disorders, including autoimmune diseases, cancer and diseases of the GI tract. Contact: Andy Round
|
 |
|
Pregnapause Ltd
Description: Developing improved success rates for embryo implantation for lab rodents, cattle, horses and other domesticated animals. Contact: Andy Round
|
 |
|
Rheokinisis Ltd
Description: Development of devices that give immediate viscosity and flow behaviour (rheology) measurements on slurries and other complex fluids. Contact: Laura Bond
|
 |
|
Rigicom Ltd
Description: Rigicom Ltd has been created to commercialise the technology for self-reinforced polymer composites (also known as Hot Compaction). These composite materials are produced from stretched polymer tapes which are compacted to create light-weight impact-resistant sheets with numerous applications from automotive protection to sports goods. The Company is seeking new licensees for this technology, which can be used across a wide range of polymers including polyethylene and polypropylene. Contact: Rob Rule
|
 |
|
vVax Ltd
Description: Therapeutic application of a novel strategy for delivering proteins for vaccination. Contact: Andy Round
|
Seedcorn level
 |
|
Chamelic Ltd
Description: Stimulus responsive polymers to serve the coatings and additives markets. Website: www.chamelic.co.uk Contact: Laura Bond
|
 |
|
Dispersia Ltd
Description: dispersia ltd create and produce advanced thermal transfer fluids based on our proprietary nano-particle technologies. Website: www.dispersia.com Contact: Rob Rule
|
 |
|
Leeds Lithium Power Ltd
Description: Developments in the fields of polymer gel electrolytes and a roll-to-roll battery production process. Website: www.leedslithiumpower.com Contact: Rob Rule
|
 |
|
Leeds Reproductive Biosciences Ltd
Description: LRB is developing diagnostic tests to improve success rates for IVF treatment. Contact: Andy Round
|
 |
|
Structure Vision Ltd
Description: The worlds first automated industrial packing analysis software, used by a number of blue chip clients across the Nuclear, Chemical and Pharmaceutical industries. Website: www.structurevision.com Contact: Bob Ward, CEO Email: r.ward@structurevision.com
|
 |
|
Tissue Regenix Ltd
Description: Tissue Regenix develop and commercialise acellular tissue repair products to meet the need for donor tissue for a variety of surgical procedures. Website: www.tissueregenix.com Contact: Simon Graindorge
|
 |
|
Xeros Ltd
Description: Xeros Ltd is developing an alternative to traditional aqueous-based domestic laundering systems as well as solvent-based commercial garment cleaning. Website: www.xerosltd.com Contact: Rob Rule
|
Later Stage Listed/Growth stage
 |
|
Avacta Group plc
Description: Developing advanced molecular detection and analysis technologies for the biopharmaceutical, homeland security, defence and medical diagnostics industries. Website: www.avacta.com Contact: Alastair Smith, CEO
|
 |
|
GETECH Group plc
Description: Founded in 1986, GETECH is a leading company providing gravity and magnetic data and related management and interpretation services to the international oil and mining exploration industry. Website: www.getech.com Contact: Raymond Wolfson, CEO
|
 |
|
Green Chemicals Plc
Description: Green Chemicals plc is engaged in researching and developing cleaner, greener and safer chemicals for global industrial use. Website: www.greenchemicalsplc.com Contact: Stephen Winston, interim CEO
|
 |
|
LUTO Research Ltd
Description: LUTO Research Ltd specialises in enhancing, editing and user testing of patient information for pharmaceutical companies. Website: www.luto.co.uk Contact: David Wood, CEO
|
 |
|
Photopharmica Ltd
Description: Photopharmica discovers and develops photosensitisers and light sources for medical use. Website: www.photopharmica.com Contact: John Lyon, CEO
|
 |
|
Tracsis Plc
Description: A range of products that assist in the development of optimised crew schedules for all types of on-board labour. Website: www.tracsis.com Contact: John McArthur, CEO
|
 |
|
Syntopix Group Plc
Description: A speciality pharmaceutical research and development company who seek to identify compounds and develop products that treat dermatological conditions, principally acne and staphylococcal infections including MRSA. Website: www.syntopix.com Contact: Stephen Jones, CEO
|
Return to top
|